POSTER SESSION V
Wednesday, March 24, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
235
p16 Expression in Squamous Cell Carcinoma in Multiple Organ Sites
(1772)
OA Asojo, H Al-Ghawi, K Wikenheiser-Brokamp, G Hill, F Lucas, QJ Zhai - University of Cincinnati, Cincinnati, OH; Greater Cincinnati Pathologists Inc, Cincinnati, OH
A Role for HPV Analysis in Distinguishing Second Primary Tumors from Lung Metastases in Patients with Head and Neck Squamous Cell Carcinoma
(1779)
JA Bishop, PB Illei, WH Westra - The Johns Hopkins Medical Institutions, Baltimore, MD
Age-Related CDKN2A (p16) Promoter Methylation and Outcome in Surgically Treated Stage I-II Non-Small Cell Lung Cancer Patients
(1780)
DP Bradly, L Buckingham, J Coon, M Liptay, P Bonomi, P Gattuso - Rush University Medical Center, Chicago, IL
Usefulness of Ki-67 for Predicting Metastatic Potential of Carcinoid Tumour of the Lung: A Study of 48 Cases
(1845)
A Shibani, N Panjawani, A Arab, R Inculet, LW Stitt, JG Shepherd, MG Joseph - London Health Sciences Centre, London, ON, Canada
Usefulness of EZH2 and IMP3 in Discriminating High Grade Neuroendocrine Carcinoma from Carcinoids in Small Biopsies and Fine Needle Aspiration Specimens of the Lung
(1793)
JJ Findeis-Hosey, Q Yang, LA McMahon, BO Spaulding, F Li, H Xu - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA
IMP3: An Immunohistochemical Marker for Invasive Squamous Cell Carcinoma and Its High-Grade Precursor Lesions of the Lung
(1795)
JJ Findeis-Hosey, Q Yang, LA McMahon, BO Spaulding, F Li, H Xu - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA
Different Prevalence of Transactivating (TA) p63 and Non-TAp63 Isoforms in Pulmonary Adenocarcinomas: A Useful Diagnostic Tool
(1838)
G Pelosi, A Sonzogni, M Papotti, L Righi, G Rossi, G Viale - European Institute of Oncology and University of Milan School of Medicine, Milan, Italy; University of Turin, Orbassano Hospital, Turin, Italy; Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
Expression of Squamous Markers in Lung Adenocarcinoma (AD): Clinicopathologic and Molecular Correlates, and Implications for Differentiation from Squamous Cell Carcinoma
(1770)
DC Ang, H Ghaffar, MF Zakowski, J Teruya-Feldstein, AL Moreira, N Rekhtman - Memorial Sloan-Kettering Cancer Center, New York, NY
Subclassification of Poorly Differentiated Non Small Cell Carcinoma on Small Biopsy Specimens: Utility of a Panel of Immunohistochemical Stains
(1830)
S Mukhopadhyay, A Katzenstein - State University of New York Upstate Medical University, Syracuse, NY
Immunohistochemical Analysis of Napsin A in 77 Lung Carcinomas and 509 Non-Pulmonary Malignancies
(1771)
ME Arcila, N Rekhtman, J Teruja-Feldstein - Memorial Sloan Kettering Cancer Center, New York, NY
Napsin A Is Frequently Expressed in Pulmonary Adenocarcinoma but Rarely Detected in Neuroendocrine Tumors of the Lung
(1794)
JJ Findeis-Hosey, Q Yang, LA McMahon, F Li, H Xu - University of Rochester Medical Center, Rochester, NY
Distinguishing Adenocarcinoma from Squamous Cell Carcinoma in the Lung Using Double Stains: Napsin A and p63 and TTF-1 and CD141
(1852)
D Tacha, D Zhou, RL Henshall-Powell - Biocare Medical, Concord
Clinical Utility of Immunohistochemistry for the Diagnosis of Lung Squamous Cell Carcinoma in Biopsy and Cytologic Specimens
(1789)
M de Peralta-Venturina, D Phan, R Parakh, T Fennell, M Amin, A Marchevsky - Cedars Sinai Medical Center, Los Angeles, CA; William Beaumont Hospital, Royal Oak, MI
Subtyping of Non-Small Cell Lung Carcinoma (NSCLC): Comparison of Cytology and Small Biopsy Specimens
(1848)
CS Sigel, MA Friedlander, MF Zakowski, AL Moreira, N Rekhtman - Memorial Sloan-Kettering Cancer Center, New York, NY
Prognostic Significance of Cytologic Features of Lung Adenocarcinoma, Mixed Subtype
(1849)
CS Sigel, DE Rudomina, N Rekhtman, WD Travis, AL Moreira - Memorial Sloan-Kettering Cancer Center, New York
Minute Nests of Neuroendocrine Cells in the Mediastinal Lymph Nodes: Real Metastasis?
(1819)
F Li, X Wang, LA McMahon, Q Yang, H Xu - University of Rochestyer Medical Center, Rochester
Metastatic Endometrial Stromal Sarcoma in the Lung: Importance of Immunohistochemical Staining, Clinical History and Imaging Studies
(1826)
MJ Mentrikoski, C Zhao, J Zhang, HL Wang, LA McMahon, Q Yang, F Li, H Xu - University of Rochester Medical Center, Rochester; University of Pittsburgh Medical Center, Pittsburgh; Mayo Clinic, Rochester; Cedars-Sinai Medical Center, Los Angeles
Cytological, Histological, and Immunohistochemical Findings of Pulmonary Carcinomas with Basaloid Features
(1788)
JP Crapanzano, K Loukeris, AC Borczuk, A Saqi - Columbia University Medical Center, New York, NY; Weill Cornell Medical Center, New York, NY
Signet Ring Cell Features (SRCF) in Lung Adenocarcinoma: A Cytologic Feature or a Histologic Subtype?
(1787)
PR Cohen, A Yoshizawa, N Motoi, GJ Riely, MG Kris, BJ Park, VW Rusch, WD Travis - Memorial Sloan Kettering Cancer Center, New York, NY; Kyoto University Hospital, Kyoto, Japan; The Cancer Institute Hospital, JFCR, Tokyo, Japan
Elastic Tissue Stain: A Valuable Diagnostic Tool for the Assessment of Visceral Pleura Invasion in Patients with Non-Small Cell Lung Cancer
(1808)
M Kamionek, A Akalin, K Dresser, S Baker, A Fraire - University of Massachusetts Medical School, Worcester, MA
Alveolar Trapping in Non Small Cell Carcinoma of Lung
(1807)
FM Izquierdo, N Moreno, E Honrado, ML Herranz, MA Canizares, F Gonzalez, E Alvarez - Hospital de Leon, Leon, Spain; Hospital Gregorio Maranon, Madrid, Spain; Hospital Xeral, Vigo, Pontevedra, Spain
button next to any title to add to Itinerary Planner...
Add
